Published on December 4, 2017
Why doesn’t CLL treatment always start immediately after a CLL diagnosis? The watch-and-wait period can be unsettling for some chronic lymphocytic leukemia (CLL) patients, leaving them wondering why a potentially life-threatening condition hasn’t received treatment yet. Tune in to find out from Dr. Michael Keating of MD Anderson Cancer Center, as he explains some of the variables that influence the course of care.
Provided by CLL Global Research Foundation, which received support from AbbVie Inc., Gilead Sciences, TG Therapeutics, Pharmacyclics LLC and Janssen Biotech, Inc., and Genentech. Produced by Patient Power in collaboration with The US Oncology Network, Compass Oncology, and Willamette Valley Cancer Institute and Research Center.
Thank you, Andrew and team, for creating the best information source on the web for CLL.